Pioneering Houston Doctor, V. Craig Jordan, Ph.D. Dies at 76

HOUSTON — Pharmacologist V. Craig Jordan, Ph.D., a Houston pioneer in the fight against breast cancer, has died at the age of 76, according to the MD Anderson Cancer Center.

Jordan discovered SERMs – or selective estrogen receptor modules – and developed groundbreaking treatments for women in their fight against cancer. It proved that the drug tamoxifen, originally designed to block estrogen and prevent pregnancy, could also be used to stop cancer. He became known as the “father of tamoxifen.”

“Dr. Jordan leaves behind a remarkable legacy that will continue to influence cancer research and treatment for generations to come,” said MD Anderson President Peter WT Pisters, MD, in a post on the website. Cancer Center Web. “Craig’s passing is a profound loss to the scientific community and to all those who had the privilege of knowing and working with him. »

A native of New Braunfels, Jordan spent time at the University of Leeds, Switzerland’s Ludwig Institute, the University of Wisconsin-Madison, Northwestern University, Fox Chase Cancer Center and Georgetown University before joining MD Anderson.

You can learn more about Dr. Jordan’s achievements in breast cancer treatment, his military experience and much more on the MD Anderson website.